Role of suppressor of cytokine signaling 3 (SOCS3) in altering activated microglia phenotype in APPswe/PS1dE9 mice

Manuscript Number: 

16-0887R1

Author(s): 
Mai Fujikura, Shin Hisahara, Naotoshi Iwahara, Jun Kawamata, Tatsuo Manabe, Akihiro Matsumura, Takashi Matsushita, Taro Saito, Shun Shimohama, Hiromi Suzuki, Syuuichirou Suzuki, Kazuki Yokokawa

Disclosures

Mai Fujikura

  • Nothing to Disclose

Shin Hisahara

  • Nothing to Disclose

Naotoshi Iwahara

  • Nothing to Disclose

Jun Kawamata

  • Nothing to Disclose

Tatsuo Manabe

  • Nothing to Disclose

Akihiro Matsumura

  • Nothing to Disclose

Takashi Matsushita

  • Nothing to Disclose

Taro Saito

  • Nothing to Disclose

Shun Shimohama

  • Consulting Fees:
    Toyama Chemical Co., LTD
    Lecture Fees:
    Novartis Pharma Co.,Takeda Pharmaceutical Co., Daiichisankyo Pharma Co., Jansen Pharma Co., Eisai Pharma Co., and Mitsubishi Tanabe Pharma Co.
    Grants
    • Agency: 
      Novartis Pharma Co.
      Dates: 
      2013-2016
    • Agency: 
      Daiichisankyo Pharma Co.
      Dates: 
      2013-2016
    • Agency: 
      Eisai Pharma Co.
      Dates: 
      2013-2016
    • Agency: 
      Jansen Pharma Co.
      Dates: 
      2013-2016

Hiromi Suzuki

  • Nothing to Disclose

Syuuichirou Suzuki

  • Nothing to Disclose

Kazuki Yokokawa

  • Nothing to Disclose